The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
21 January 2016
Employment effect (start)
22 January 2016
Foreseen end date
22 June 2016
Description
Pharmaceutical company Lek, which is part of the global generics leader Sandoz (Novartis), has enlarged its bio-pharmaceutical development centre in MengeÅ¡, near Ljubljana. The investment in new laboratory facility, which is worth over 10 million Euro, will allow the company to develop final dosage form for biosimilars and not only active ingredients. As a result, 100 new jobs are going to be created in MengeÅ¡.  An important incentive for the development of biosimilars was Sandoz's entry in the US market in 2015.Â
Â
Â
Sources
21 January 2016: Delo
21 January 2016: Lek (Press release)
Citation
Eurofound (2016), Lek, Business expansion in Slovenia, factsheet number 86249, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/86249.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
